Electronics Ethics Government Marketing 
European Pharmaceutical Review
MARCH 12, 2024
Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance. Good documentation practices.
European Pharmaceutical Review
JANUARY 9, 2024
Accelerated drug discovery: Simulations and predictive models powered by AI will speed up the drug development process, effectively slashing time to market for drugs. A Survey of Recent Advances in Deep Learning Techniques for Electronic Health Record (EHR) Analysis. Available from: [link] Rajkomar A, Dean J, Kohane I. N Engl J Med.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
JUNE 16, 2023
For more than a decade, access to deidentified sources of real-world data—especially administrative claims, patient registries, and more recently electronic health records (EHRs)—has been informing unmet needs, population sizing and forecasting, and commercialization and marketing activities.
Cadensee
JULY 20, 2021
21:40 At what scale is breaking away from traditional channel to market is happening on a wide scale in the industry? 52:21 Uri's opinion about the main problem that needs to be solved for the healthcare market with technology. It might be silly question but bringing a drug to market takes many, many years.
Pharmaceutical Technology
MAY 4, 2023
Rigorous standards established by governing bodies include consent forms and protocols related to storing and sharing of PHI. Violations specifically included lack of analysis to determine vulnerabilities to electronic PHI and failure to implement an authentication process to safeguard information. million consumers.
Expert insights. Personalized for you.
98 
Let's personalize your content